CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 75 enrolled
Drug / intervention
Minor Salivary gland Biopsy +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04001556
NCT04001556N/ACompleted
CompareCT.gov

RElevance of UltraSonography for Assessing Salivary Gland Involvement in Systemic Sclerosis (SSc)

Rennes University Hospital·interventional·Posted Jun 28, 2019·Updated Apr 5, 2022

In Brief

A clinical study evaluating Minor Salivary gland Biopsy, ARFI, and 1 other intervention for Systemic Sclerosis. Completed, enrolled 75 participants across 3 sites.

Detailed Summary

As fibrosis of salivary glands is supposed to be the main mechanism involved in Systemic sclerosis (SSc)-associated sicca syndrome, Ultrasonography , biopsy and measuring gland elasticity (by ARFI (Acoustic Radiation Force Impulse)) in SSc patients could also constitute a relevant method to assess the potential alterations of echostructure of major salivary glands and the fibrosis of Salivary Glands in this disease.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Sclerosis
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJun 28, 2019
Enrollment StartDec 2, 2019
Primary CompletionMar 4, 2022
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 7.0 years ago

Interventions

Minor Salivary gland Biopsyother

Minor salivary gland biopsy with injection of lidocain

ARFIother

Acoustic Radiation Force Impulse on Major Salivary Glands

MSG USother

Ultrasonography of Major Salivary Glands